|Bid||78.35 x 800|
|Ask||78.36 x 300|
|Day's Range||78.02 - 79.02|
|52 Week Range||66.54 - 80.68|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.09%|
The Federal Reserve typically hikes interest rates to obviate an overheating economy during the later stages of an economic cycle, typically foreshadowing the eventual end of a bull market. Nevertheless, ...
It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.
On June 19, 2017, Melinta Therapeutics announced that its drug, Baxdela, had secured regulatory approval from the FDA as a treatment option for adult patients suffering from acute bacterial skin and skin ...
Ligand Pharmaceuticals (LGND) receives royalties from Novartis on Promacta’s sales according to a tiered annual payment structure.
In 2Q17, Ligand Pharmaceuticals (LGND) reported revenues of ~$28.0 million, representing year-over-year growth of ~43.4%. LGND received ~$14.2 million in royalties, a year-over-year rise of 45.7%.
One of the most vexing scenarios facing investors this year has been the ongoing disappointment delivered by U.S. small-caps and the corresponding exchange-traded funds. For instance, the iShares Russell ...
Flotek stock will likely close between $6.42 and $5.50 in the next seven days. Flotek's stock price was $5.96 on August 10, 2017.
Flotek Industries’ (FTK) management expressed optimism about improving pricing for FTK’s complex nano-Fluid (or CnF) products despite higher raw material costs.
U.S. small caps have been laggards for essentially all of this year, but the current state of affairs for smaller U.S. stocks is getting downright troubling. While large-cap indexes, such as the Dow Jones ...